The Role of Cardiovascular Magnetic Resonance in the Evaluation of Valve Disease

被引：10

作者：

Karamitsos, Theodoros D. ^{[1
]}

Myerson, Saul G. ^{[1
]}

机构：

[1] Univ Oxford, Dept Cardiovasc Med, Ctr Clin Magnet Resonance Res, Oxford, England

来源：

PROGRESS IN CARDIOVASCULAR DISEASES | 2011年 / 54卷 / 03期

关键词：

Cardiovascular magnetic resonance; Phase contrast velocity mapping; Stenosis; Regurgitation; Flow quantification; LEFT-VENTRICULAR MASS; AORTIC REGURGITATION; MITRAL REGURGITATION; PULMONARY VALVE; INTERSTUDY REPRODUCIBILITY; REPAIRED TETRALOGY; CARDIAC-OUTPUT; HEART-FAILURE; ORIFICE AREA; VELOCITY;

D O I：

10.1016/j.pcad.2011.08.005

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Echocardiography is the primary imaging modality for initial assessment and longitudinal evaluation of patients with valvular heart disease. Cardiovascular magnetic resonance (CMR) has emerged as an additional or alternative modality in these patients providing clinically useful information not only about the valve lesion itself but also about the consequences for the relevant ventricle. Other unique capabilities of CMR include the assessment of surrounding anatomy (eg, great vessels) and the evaluation of myocardial scar or fibrosis. This review will highlight the role of CMR in the assessment of patients with valve disease with particular emphasis on the advantages of this imaging modality in key areas. (Prog Cardiovasc Dis 2011;54:276-286) (C) 2011 Elsevier Inc. All rights reserved.

引用

页码：276 / 286

页数：11

共 67 条

[1] Ammash Naser M, 2007, Congenit Heart Dis, V2, P386, DOI 10.1111/j.1747-0803.2007.00131.x
[2] [Anonymous], 2011, REFERENCE MANUAL MAG
[3] The potential of myocardial perfusion scintigraphy for risk stratification of asymptomatic patients with type 2 diabetes
Bax, Jeroen J.
Bonow, Robert O.
Tschoepe, Diethelm
Inzucchi, Silvio E.
Barrett, Eugene
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (04) : 754 - 760
[4] Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance - Are they interchangeable?
Bellenger, NG
Burgess, MI
Ray, SG
Lahiri, A
Coats, AJS
Cleland, JGF
Pennell, DJ
[J]. EUROPEAN HEART JOURNAL, 2000, 21 (16) : 1387 - 1396
[5] Aortic Regurgitation: Time to Reassess Timing of Valve Replacement?
Bonow, Robert O.
[J]. JACC-CARDIOVASCULAR IMAGING, 2011, 4 (03) : 231 - 233
[6] Botnar R, 2000, MAGN RESON MATER PHY, V10, P18
[7] Cardiovascular Magnetic Resonance for Direct Assessment of Anatomic Regurgitant Orifice in Mitral Regurgitation
Buchner, Stefan
Debl, Kurt
Poschenrieder, Florian
Feuerbach, Stefan
Riegger, Guenter A. J.
Luchner, Andreas
Djavidani, Behrus
[J]. CIRCULATION-CARDIOVASCULAR IMAGING, 2008, 1 (02) : 148 - 155
[8] Towards comprehensive assessment of mitral regurgitation using cardiovascular magnetic resonance
Chan, K. M. John
Wage, Ricardo
Symmonds, Karen
Rahman-Haley, Shelley
Mohiaddin, Raad H.
Firmin, David N.
Pepper, John R.
Pennell, Dudley J.
Kilner, Philip J.
[J]. JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE, 2008, 10 (1)
[9] Chatzimavroudis GP, 1998, J HEART VALVE DIS, V7, P94
[10] ACC/AHA/ASE 2003 guideline update for the clinical application of Echocardiography: Summary article
Cheitlin, MD
Armstrong, WF
Aurigemma, GP
Beller, GA
Bierman, FZ
Davis, JL
Douglas, PS
Faxon, DP
Gillam, LD
Kimball, TR
Kussmaul, WG
Pearlman, AS
Philbrick, JT
Rakowski, H
Thys, DM
Antman, EM
Smith, SC
Alpert, JS
Gregoratos, G
Anderson, JL
Hiratzka, LF
Faxon, DP
Hunt, SA
Fuster, V
Jacobs, AK
Gibbons, RJ
Russell, RO
[J]. JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2003, 16 (10) : 1091 - 1110

← 1 2 3 4 5 6 7 →